𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Absence of modulation of CD4+CD25high regulatory T cells in CTCL patients treated with bexarotene

✍ Scribed by Anne Chantal Knol; Gaëlle Quéreux; Anabelle Brocard; Fabienne Ballanger; Amir Khammari; Jean-Michel Nguyen; Brigitte Dréno

Book ID
111244595
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
394 KB
Volume
19
Category
Article
ISSN
0906-6705

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CD4+CD25+ regulatory T cells in patients
CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies : Possible involvement of regulatory T cells in disease progression
✍ Tetsuro Sasada; Motohide Kimura; Yuka Yoshida; Michiyuki Kanai; Arimichi Takabay 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

## Abstract ## BACKGROUND Active suppression by CD4^+^CD25^+^ regulatory T cells plays an important role in the down‐regulation of the response of T cells to foreign and self antigens. Experimental tumor models in mice revealed that regulatory T cells inhibit antitumor immune responses. The purpos

IDO expands human CD4+CD25high regulator
IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells
✍ Marcelo Hill; Séverine Tanguy-Royer; Pierre Royer; Christine Chauveau; Kashif As 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB

## Abstract We have previously shown that human monocyte‐derived dendritic cells (DC) express indoleamine 2,3‐dioxygenase (IDO), as well as several other enzymes of the kynurenine pathway at the mRNA level upon maturation. The tolerogenic mechanisms of this pathway remain unclear. Here we show that